Related Experiment Video
Updated: Aug 14, 2026
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Design of clinical trials in advanced prostate cancer: avoiding the dead ends
1Department of Urology, Radboud University Nijmegen Medical Centre, Geert Grooteplein 30, Nijmegen, the Netherlands.
Abstract:
Despite more than 30 years of clinical trials, investigations in prostate cancer have not succeeded in making advances comparable to those in other branches of research, such as breast cancer. Indeed, prostate cancer trials have repeatedly run into a series of "dead ends", as investigators face the problems of inadequate funding for research, treatments that result in only minimal improvements in survival, and lack of treatment options that have sufficient prospects for success. This article briefly reviews the strategies behind clinical investigations into prostate cancer over the last three decades, evaluates the pitfalls that have hindered research, and makes suggestions for the appropriate design of clinical trials that are safe and beneficial to patients while maintaining cost-effectiveness and accountability to patients and society.
Insights
Prostate cancer research has faced challenges for decades, with clinical trials often hitting dead ends due to funding issues and limited treatment options. This review suggests strategies for more effective and cost-efficient prostate cancer clinical trial design.
Area of Science:
- Oncology
- Clinical Research
Background:
- Prostate cancer research has lagged behind other fields like breast cancer despite extensive clinical trials.
- Numerous prostate cancer trials have encountered significant obstacles, hindering progress.
Purpose of the Study:
- To review prostate cancer clinical investigation strategies over the past 30 years.
- To evaluate the challenges that have impeded research in this area.
- To propose improved clinical trial designs that are safe, effective, and cost-efficient.
Main Methods:
- Review of historical clinical trial strategies in prostate cancer.
- Analysis of common pitfalls and challenges in prostate cancer research.
- Formulation of recommendations for future clinical trial design.
Main Results:
- Identified inadequate funding, minimal survival improvements, and lack of promising treatments as key barriers.
- Highlighted repeated "dead ends" in clinical investigations.
- Emphasized the need for strategic improvements in trial design and execution.
Conclusions:
- Past prostate cancer clinical trials have been hampered by systemic issues.
- Future research requires a strategic redesign of clinical trials to ensure patient benefit, cost-effectiveness, and accountability.
- Optimized trial designs are crucial for advancing prostate cancer treatment and patient outcomes.
Related Concept Videos
01:16Clinical Trials
There are four phases in a clinical trial. A phase one...
01:11Clinical Trials: Overview
01:21Cancer Survival Analysis
01:28Preclinical Development: Overview